GE HealthCare Technologies Inc.GEHC
What GE HealthCare Technologies Inc. does.
GE HealthCare Technologies Inc. (“GE HealthCare,” the “Company,” “our,” “us,” or “we”) is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. We have approximately 54,000 colleagues dedicated to our purpose to create a world where healthcare has no limits. Serving patients and providers for nearly 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine to help clinicians deliver more personalized, precise patient care. This is complemented by our broad service capabilities and dedication to quality and integrity with a strong operational culture, supported by our lean business system, Heartbeat.
We generate revenue from the sale of medical devices, consumable products, service capabilities, and AI-enabled cloud and software solutions. We serve customers in over 160 countries with a global team of approximately 9,700 sales professionals and 8,900 field service engineers. Our customers are hospitals, health systems, and researchers, including public, private, academic, and government institutions. Our comprehensive portfolio of solutions addresses the biggest challenges facing healthcare today, and is designed to advance care delivery for customers, reduce disease burden, enable better patient outcomes, and drive sustainable growth for the company. These qualities foster trust, loyalty, and partnership with our global customer base. Our revenues, operating profits, and cash flows vary from quarter to quarter. Financial results in the fourth quarter have historically been higher than in other quarters due to the spending patterns of our customers.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $17.6B | $18.3B | $19.6B | $19.7B | $20.6B |
| Net income | — | $2.2B | $1.9B | $1.6B | $2.0B | $2.1B |
| Free cash flow | — | $1.4B | $1.8B | $1.7B | $1.6B | $1.5B |
More on GEHC.
- GE HealthCare Technologies Inc. summary
- GE HealthCare Technologies Inc. financial statements
- GE HealthCare Technologies Inc. key metrics
- GE HealthCare Technologies Inc. health scores and style box
- GE HealthCare Technologies Inc. earnings
- GE HealthCare Technologies Inc. dividends
- GE HealthCare Technologies Inc. valuation
- GE HealthCare Technologies Inc. ownership and insiders
- GE HealthCare Technologies Inc. peers
Figures from GE HealthCare Technologies Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.